| Donald W Hayes, MD | |
|
2116 Chapel Hill Rd, Birmingham, AL 35216-5106 | |
| (205) 822-8038 | |
| (205) 822-8040 |
| Full Name | Donald W Hayes |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 25 Years |
| Location | 2116 Chapel Hill Rd, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093754566 | NPI | - | NPPES |
| 051500908 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 00245 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Special Care Podiatry Of Tennessee, Llc | 8820398696 | 10 |
News Archive
Karen Davis will retire as president of the Commonwealth Fund, a health care research foundation, at the end of 2012. The foundation, based in New York, has hired an executive search firm to find Davis' successor. In a news release announcing her retirement, Davis said she would spend her final year helping with the leadership transition and "pursuing opportunities for contributing toward the work that is so important to ensuring that every American receives the best possible care and the opportunity to lead healthy, productive lives."
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
A recent study by researchers in France shows how differences in infection history and viral spread patterns are important factors in predicting the time course of a localized epidemic of SARS-CoV-2.
Proscia Inc., a data solutions provider for digital pathology, and Samsung Medical Center, South Korea's preeminent clinical and biomedical research institute, today announced a partnership focused on developing tools that enable predictive medicine in the fight against cancer.
IsoRay, Inc. announced today it has received final approval from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer. In conjunction with the previously announced FDA clearance, the Washington State approval represents IsoRay's final regulatory hurdle to commence the sale of its GliaSite brain cancer treatment in the United States.
› Verified 2 days ago
| Provider Name | Special Care Podiatry Of Tennessee, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780072371 PECOS PAC ID: 8820398696 Enrollment ID: O20151130001704 |
News Archive
Karen Davis will retire as president of the Commonwealth Fund, a health care research foundation, at the end of 2012. The foundation, based in New York, has hired an executive search firm to find Davis' successor. In a news release announcing her retirement, Davis said she would spend her final year helping with the leadership transition and "pursuing opportunities for contributing toward the work that is so important to ensuring that every American receives the best possible care and the opportunity to lead healthy, productive lives."
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
A recent study by researchers in France shows how differences in infection history and viral spread patterns are important factors in predicting the time course of a localized epidemic of SARS-CoV-2.
Proscia Inc., a data solutions provider for digital pathology, and Samsung Medical Center, South Korea's preeminent clinical and biomedical research institute, today announced a partnership focused on developing tools that enable predictive medicine in the fight against cancer.
IsoRay, Inc. announced today it has received final approval from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer. In conjunction with the previously announced FDA clearance, the Washington State approval represents IsoRay's final regulatory hurdle to commence the sale of its GliaSite brain cancer treatment in the United States.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donald W Hayes, MD 2116 Chapel Hill Rd, Birmingham, AL 35216-5106 Ph: (205) 822-8038 | Donald W Hayes, MD 2116 Chapel Hill Rd, Birmingham, AL 35216-5106 Ph: (205) 822-8038 |
News Archive
Karen Davis will retire as president of the Commonwealth Fund, a health care research foundation, at the end of 2012. The foundation, based in New York, has hired an executive search firm to find Davis' successor. In a news release announcing her retirement, Davis said she would spend her final year helping with the leadership transition and "pursuing opportunities for contributing toward the work that is so important to ensuring that every American receives the best possible care and the opportunity to lead healthy, productive lives."
Shionogi & Co., Ltd. and QuatRx Pharmaceuticals Company, a privately-held pharmaceutical company, today announced that they have entered into a worldwide license agreement to develop and market ospemifene, a selective estrogen receptor modulator ("SERM").
A recent study by researchers in France shows how differences in infection history and viral spread patterns are important factors in predicting the time course of a localized epidemic of SARS-CoV-2.
Proscia Inc., a data solutions provider for digital pathology, and Samsung Medical Center, South Korea's preeminent clinical and biomedical research institute, today announced a partnership focused on developing tools that enable predictive medicine in the fight against cancer.
IsoRay, Inc. announced today it has received final approval from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer. In conjunction with the previously announced FDA clearance, the Washington State approval represents IsoRay's final regulatory hurdle to commence the sale of its GliaSite brain cancer treatment in the United States.
› Verified 2 days ago
Ag Podiatric Specialist And Associates Podiatrist Medicare: Medicare Enrolled Practice Location: 1529 Bessemer Rd, Birmingham, AL 35208 Phone: 205-925-5272 Fax: 205-925-5278 | |
Trussville Foot Care Center Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1930 Edwards Lake Rd, Suite 138, Birmingham, AL 35235 Phone: 205-661-1400 | |
William David Campbell, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1 Independence Plz Ste 530, Birmingham, AL 35209 Phone: 205-445-0661 Fax: 205-445-0664 | |
Total Foot Care Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1930 Edwards Lake Rd, Birmingham, AL 35235 Phone: 205-655-7337 Fax: 205-655-7338 | |
John L Roberson Jr., DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 805 St. Vincent's Drive, Suite 420, Birmingham, AL 35205 Phone: 205-324-8511 Fax: 205-324-0319 | |
Ankles & Feet Podiatry Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5511 Highway 280, Ste 124, Birmingham, AL 35242 Phone: 205-980-2005 Fax: 205-981-4513 |